BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25897948)

  • 1. Common germline polymorphisms associated with breast cancer-specific survival.
    Pirie A; Guo Q; Kraft P; Canisius S; Eccles DM; Rahman N; Nevanlinna H; Chen C; Khan S; Tyrer J; Bolla MK; Wang Q; Dennis J; Michailidou K; Lush M; Dunning AM; Shah M; Czene K; Darabi H; Eriksson M; Lambrechts D; Weltens C; Leunen K; van Ongeval C; Nordestgaard BG; Nielsen SF; Flyger H; Rudolph A; Seibold P; Flesch-Janys D; Blomqvist C; Aittomäki K; Fagerholm R; Muranen TA; Olsen JE; Hallberg E; Vachon C; Knight JA; Glendon G; Mulligan AM; Broeks A; Cornelissen S; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Cross SS; Reed MW; Giles GG; Milne RL; McLean C; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Hooning MJ; Hollestelle A; Martens JW; van den Ouweland AM; Marme F; Schneeweiss A; Yang R; Burwinkel B; Figueroa J; Chanock SJ; Lissowska J; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Brenner H; Butterbach K; Holleczek B; Kataja V; Kosma VM; Hartikainen JM; Li J; Brand JS; Humphreys K; Devilee P; Tollenaar RA; Seynaeve C; Radice P; Peterlongo P; Manoukian S; Ficarazzi F; Beckmann MW; Hein A; Ekici AB; Balleine R; Phillips KA; ; Benitez J; Zamora MP; Perez JI; Menéndez P; Jakubowska A; Lubinski J; Gronwald J; Durda K; Hamann U; Kabisch M; Ulmer HU; Rüdiger T; Margolin S; Kristensen V; Nord S; ; Evans DG; Abraham J; Earl H; Poole CJ; Hiller L; Dunn JA; Bowden S; Yang R; Campa D; Diver WR; Gapstur SM; Gaudet MM; Hankinson S; Hoover RN; Hüsing A; Kaaks R; Machiela MJ; Willett W; Barrdahl M; Canzian F; Chin SF; Caldas C; Hunter DJ; Lindstrom S; Garcia-Closas M; Couch FJ; Chenevix-Trench G; Mannermaa A; Andrulis IL; Hall P; Chang-Claude J; Easton DF; Bojesen SE; Cox A; Fasching PA; Pharoah PD; Schmidt MK
    Breast Cancer Res; 2015 Apr; 17(1):58. PubMed ID: 25897948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.
    Morra A; Escala-Garcia M; Beesley J; Keeman R; Canisius S; Ahearn TU; Andrulis IL; Anton-Culver H; Arndt V; Auer PL; Augustinsson A; Beane Freeman LE; Becher H; Beckmann MW; Behrens S; Bojesen SE; Bolla MK; Brenner H; Brüning T; Buys SS; Caan B; Campa D; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Cheng TD; Clarke CL; ; Colonna SV; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Dennis J; Dörk T; Dossus L; Dunning AM; Dwek M; Eccles DM; Ekici AB; Eliassen AH; Eriksson M; Evans DG; Fasching PA; Flyger H; Fritschi L; Gago-Dominguez M; García-Sáenz JA; Giles GG; Grip M; Guénel P; Gündert M; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Hart SN; Hartikainen JM; Hartmann A; He W; Hooning MJ; Hoppe R; Hopper JL; Howell A; Hunter DJ; ; ; Jager A; Jakubowska A; Janni W; John EM; Jung AY; Kaaks R; Keupers M; Kitahara CM; Koutros S; Kraft P; Kristensen VN; Kurian AW; Lacey JV; Lambrechts D; Le Marchand L; Lindblom A; Linet M; Luben RN; Lubiński J; Lush M; Mannermaa A; Manoochehri M; Margolin S; Martens JWM; Martinez ME; Mavroudis D; Michailidou K; Milne RL; Mulligan AM; Muranen TA; Nevanlinna H; Newman WG; Nielsen SF; Nordestgaard BG; Olshan AF; Olsson H; Orr N; Park-Simon TW; Patel AV; Peissel B; Peterlongo P; Plaseska-Karanfilska D; Prajzendanc K; Prentice R; Presneau N; Rack B; Rennert G; Rennert HS; Rhenius V; Romero A; Roylance R; Ruebner M; Saloustros E; Sawyer EJ; Schmutzler RK; Schneeweiss A; Scott C; Shah M; Smichkoska S; Southey MC; Stone J; Surowy H; Swerdlow AJ; Tamimi RM; Tapper WJ; Teras LR; Terry MB; Tollenaar RAEM; Tomlinson I; Troester MA; Truong T; Vachon CM; Wang Q; Hurson AN; Winqvist R; Wolk A; Ziogas A; Brauch H; García-Closas M; Pharoah PDP; Easton DF; Chenevix-Trench G; Schmidt MK
    Breast Cancer Res; 2021 Aug; 23(1):86. PubMed ID: 34407845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.
    Escala-Garcia M; Canisius S; Keeman R; Beesley J; Anton-Culver H; Arndt V; Augustinsson A; Becher H; Beckmann MW; Behrens S; Bermisheva M; Bojesen SE; Bolla MK; Brenner H; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Couch FJ; Czene K; Daly MB; Dennis J; Devilee P; Dörk T; Dunning AM; Easton DF; Ekici AB; Eliassen AH; Fasching PA; Flyger H; Gago-Dominguez M; García-Closas M; García-Sáenz JA; Geisler J; Giles GG; Grip M; Gündert M; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Hartikainen JM; Heemskerk-Gerritsen BAM; Hollestelle A; Hoppe R; Hopper JL; Hunter DJ; Jacot W; Jakubowska A; John EM; Jung AY; Kaaks R; Khusnutdinova E; Koppert LB; Kraft P; Kristensen VN; Kurian AW; Lambrechts D; Le Marchand L; Lindblom A; Luben RN; Lubiński J; Mannermaa A; Manoochehri M; Margolin S; Mavroudis D; Muranen TA; Nevanlinna H; Olshan AF; Olsson H; Park-Simon TW; Patel AV; Peterlongo P; Pharoah PDP; Punie K; Radice P; Rennert G; Rennert HS; Romero A; Roylance R; Rüdiger T; Ruebner M; Saloustros E; Sawyer EJ; Schmutzler RK; Schoemaker MJ; Scott C; Southey MC; Surowy H; Swerdlow AJ; Tamimi RM; Teras LR; Thomas E; Tomlinson I; Troester MA; Vachon CM; Wang Q; Winqvist R; Wolk A; Ziogas A; ; Michailidou K; Chenevix-Trench G; Bachelot T; Schmidt MK
    Sci Rep; 2021 Oct; 11(1):19787. PubMed ID: 34611289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genome-wide association study of prognosis in breast cancer.
    Azzato EM; Pharoah PD; Harrington P; Easton DF; Greenberg D; Caporaso NE; Chanock SJ; Hoover RN; Thomas G; Hunter DJ; Kraft P
    Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1140-3. PubMed ID: 20332263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel genetic markers of breast cancer survival.
    Guo Q; Schmidt MK; Kraft P; Canisius S; Chen C; Khan S; Tyrer J; Bolla MK; Wang Q; Dennis J; Michailidou K; Lush M; Kar S; Beesley J; Dunning AM; Shah M; Czene K; Darabi H; Eriksson M; Lambrechts D; Weltens C; Leunen K; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Blomqvist C; Aittomäki K; Fagerholm R; Muranen TA; Couch FJ; Olson JE; Vachon C; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Broeks A; Hogervorst FB; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Cox A; Cross SS; Reed MW; Giles GG; Milne RL; McLean C; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Hooning MJ; Hollestelle A; Martens JW; van den Ouweland AM; Marme F; Schneeweiss A; Yang R; Burwinkel B; Figueroa J; Chanock SJ; Lissowska J; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Brenner H; Dieffenbach AK; Arndt V; Holleczek B; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Li J; Brand JS; Humphreys K; Devilee P; Tollenaar RA; Seynaeve C; Radice P; Peterlongo P; Bonanni B; Mariani P; Fasching PA; Beckmann MW; Hein A; Ekici AB; Chenevix-Trench G; Balleine R; ; Phillips KA; Benitez J; Zamora MP; Arias Perez JI; Menéndez P; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Hamann U; Kabisch M; Ulmer HU; Rüdiger T; Margolin S; Kristensen V; Nord S; Evans DG; Abraham JE; Earl HM; Hiller L; Dunn JA; Bowden S; Berg C; Campa D; Diver WR; Gapstur SM; Gaudet MM; Hankinson SE; Hoover RN; Hüsing A; Kaaks R; Machiela MJ; Willett W; Barrdahl M; Canzian F; Chin SF; Caldas C; Hunter DJ; Lindstrom S; García-Closas M; Hall P; Easton DF; Eccles DM; Rahman N; Nevanlinna H; Pharoah PD
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25890600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes.
    Bayraktar S; Thompson PA; Yoo SY; Do KA; Sahin AA; Arun BK; Bondy ML; Brewster AM
    Oncologist; 2013; 18(5):493-500. PubMed ID: 23635555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.
    Milne RL; Burwinkel B; Michailidou K; Arias-Perez JI; Zamora MP; Menéndez-Rodríguez P; Hardisson D; Mendiola M; González-Neira A; Pita G; Alonso MR; Dennis J; Wang Q; Bolla MK; Swerdlow A; Ashworth A; Orr N; Schoemaker M; Ko YD; Brauch H; Hamann U; ; Andrulis IL; Knight JA; Glendon G; Tchatchou S; ; ; Matsuo K; Ito H; Iwata H; Tajima K; Li J; Brand JS; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Lambrechts D; Peuteman G; Christiaens MR; Smeets A; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Hartman M; Hui M; Yen Lim W; Wan Chan C; Marme F; Yang R; Bugert P; Lindblom A; Margolin S; García-Closas M; Chanock SJ; Lissowska J; Figueroa JD; Bojesen SE; Nordestgaard BG; Flyger H; Hooning MJ; Kriege M; van den Ouweland AM; Koppert LB; Fletcher O; Johnson N; dos-Santos-Silva I; Peto J; Zheng W; Deming-Halverson S; Shrubsole MJ; Long J; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Cox A; Cross SS; Reed MW; Schmidt MK; Broeks A; Cornelissen S; Braaf L; Kang D; Choi JY; Park SK; Noh DY; Simard J; Dumont M; Goldberg MS; Labrèche F; Fasching PA; Hein A; Ekici AB; Beckmann MW; Radice P; Peterlongo P; Azzollini J; Barile M; Sawyer E; Tomlinson I; Kerin M; Miller N; Hopper JL; Schmidt DF; Makalic E; Southey MC; Hwang Teo S; Har Yip C; Sivanandan K; Tay WT; Shen CY; Hsiung CN; Yu JC; Hou MF; Guénel P; Truong T; Sanchez M; Mulot C; Blot W; Cai Q; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Bogdanova N; Dörk T; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Shu XO; Lu W; Gao YT; Zhang B; Couch FJ; Toland AE; ; Yannoukakos D; Sangrajrang S; McKay J; Wang X; Olson JE; Vachon C; Purrington K; Severi G; Baglietto L; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Devilee P; Tollenaar RA; Seynaeve C; Czene K; Eriksson M; Humphreys K; Darabi H; Ahmed S; Shah M; Pharoah PD; Hall P; Giles GG; Benítez J; Dunning AM; Chenevix-Trench G; Easton DF
    Hum Mol Genet; 2014 Nov; 23(22):6096-111. PubMed ID: 24943594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer.
    Campa D; Barrdahl M; Tsilidis KK; Severi G; Diver WR; Siddiq A; Chanock S; Hoover RN; Ziegler RG; Berg CD; Buys SS; Haiman CA; Henderson BE; Schumacher FR; Le Marchand L; Flesch-Janys D; Lindström S; Hunter DJ; Hankinson SE; Willett WC; Kraft P; Cox DG; Khaw KT; Tjønneland A; Dossus L; Trichopoulos D; Panico S; van Gils CH; Weiderpass E; Barricarte A; Sund M; Gaudet MM; Giles G; Southey M; Baglietto L; Chang-Claude J; Kaaks R; Canzian F
    PLoS One; 2014; 9(2):e85955. PubMed ID: 24523857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestry.
    Yang Y; Shu X; Shu XO; Bolla MK; Kweon SS; Cai Q; Michailidou K; Wang Q; Dennis J; Park B; Matsuo K; Kwong A; Park SK; Wu AH; Teo SH; Iwasaki M; Choi JY; Li J; Hartman M; Shen CY; Muir K; Lophatananon A; Li B; Wen W; Gao YT; Xiang YB; Aronson KJ; Spinell JJ; Gago-Dominguez M; John EM; Kurian AW; Chang-Claude J; Chen ST; Dörk T; Evans DGR; Schmidt MK; Shin MH; Giles GG; Milne RL; Simard J; Kubo M; Kraft P; Kang D; Easton DF; Zheng W; Long J
    EBioMedicine; 2019 Oct; 48():203-211. PubMed ID: 31629678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline DNA variations in breast cancer predisposition and prognosis: a systematic review of the literature.
    Sapkota Y
    Cytogenet Genome Res; 2014; 144(2):77-91. PubMed ID: 25401968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer.
    Gao G; Pierce BL; Olopade OI; Im HK; Huo D
    PLoS Genet; 2017 Sep; 13(9):e1006727. PubMed ID: 28957356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas.
    Hoffman J; Fejerman L; Hu D; Huntsman S; Li M; John EM; Torres-Mejia G; Kushi L; Ding YC; Weitzel J; Neuhausen SL; Lott P; ; Echeverry M; Carvajal-Carmona L; Burchard E; Eng C; Long J; Zheng W; Olopade O; Huo D; Haiman C; Ziv E
    Breast Cancer Res; 2019 Jan; 21(1):3. PubMed ID: 30642363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.
    Lei J; Rudolph A; Moysich KB; Rafiq S; Behrens S; Goode EL; Pharoah PP; Seibold P; Fasching PA; Andrulis IL; Kristensen VN; Couch FJ; Hamann U; Hooning MJ; Nevanlinna H; Eilber U; Bolla MK; Dennis J; Wang Q; Lindblom A; Mannermaa A; Lambrechts D; García-Closas M; Hall P; Chenevix-Trench G; Shah M; Luben R; Haeberle L; Ekici AB; Beckmann MW; Knight JA; Glendon G; Tchatchou S; Alnæs GI; Borresen-Dale AL; Nord S; Olson JE; Hallberg E; Vachon C; Torres D; Ulmer HU; Rüdiger T; Jager A; van Deurzen CH; Tilanus-Linthorst MM; Muranen TA; Aittomäki K; Blomqvist C; Margolin S; Kosma VM; Hartikainen JM; Kataja V; Hatse S; Wildiers H; Smeets A; Figueroa J; Chanock SJ; Lissowska J; Li J; Humphreys K; Phillips KA; ; Linn S; Cornelissen S; van den Broek SA; Kang D; Choi JY; Park SK; Yoo KY; Hsiung CN; Wu PE; Hou MF; Shen CY; Teo SH; Taib NA; Yip CH; Ho GF; Matsuo K; Ito H; Iwata H; Tajima K; Dunning AM; Benitez J; Czene K; Sucheston LE; Maishman T; Tapper WJ; Eccles D; Easton DF; Schmidt MK; Chang-Claude J
    Breast Cancer Res; 2015 Feb; 17(1):18. PubMed ID: 25849327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between germline pathogenic variants and breast cancer risk in Japanese women: The HERPACC study.
    Kasugai Y; Kohmoto T; Taniyama Y; Koyanagi YN; Usui Y; Iwase M; Oze I; Yamaguchi R; Ito H; Imoto I; Matsuo K
    Cancer Sci; 2022 Apr; 113(4):1451-1462. PubMed ID: 35218119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
    Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
    Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common genetic variants in the vitamin D pathway including genome-wide associated variants are not associated with breast cancer risk among Chinese women.
    Dorjgochoo T; Delahanty R; Lu W; Long J; Cai Q; Zheng Y; Gu K; Gao YT; Zheng W; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2313-6. PubMed ID: 21828234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between genetic variants in angiogenesis and inflammation pathway genes and breast cancer survival among Chinese women.
    Dorjgochoo T; Zheng Y; Gao YT; Ma X; Long J; Bao P; Zhang B; Wen W; Lu W; Zheng W; Shu XO; Beeghly-Fadiel A
    Cancer Epidemiol; 2013 Oct; 37(5):619-24. PubMed ID: 23850146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
    Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
    Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-ethnic follow-up of breast cancer GWAS hits using the preferential linkage disequilibrium approach.
    Zhu Q; Shepherd L; Lunetta KL; Yao S; Liu Q; Hu Q; Haddad SA; Sucheston-Campbell L; Bensen JT; Bandera EV; Rosenberg L; Liu S; Haiman CA; Olshan AF; Palmer JR; Ambrosone CB
    Oncotarget; 2016 Dec; 7(50):83160-83176. PubMed ID: 27825120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.
    Barnett GC; Thompson D; Fachal L; Kerns S; Talbot C; Elliott RM; Dorling L; Coles CE; Dearnaley DP; Rosenstein BS; Vega A; Symonds P; Yarnold J; Baynes C; Michailidou K; Dennis J; Tyrer JP; Wilkinson JS; Gómez-Caamaño A; Tanteles GA; Platte R; Mayes R; Conroy D; Maranian M; Luccarini C; Gulliford SL; Sydes MR; Hall E; Haviland J; Misra V; Titley J; Bentzen SM; Pharoah PD; Burnet NG; Dunning AM; West CM
    Radiother Oncol; 2014 May; 111(2):178-85. PubMed ID: 24785509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.